Physicians' Education Resource®, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Physicians’ Education Resource®, LLC, designates this live activity for a maximum of 26.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physicians' Education Resource®, LLC, is approved by the California Board of Registered Nursing, Provider #16669.
The program content has been reviewed by the Oncology Nursing Certification Corporation (ONCC) and is acceptable for recertification points.
Accreditation/Credit Designation for Pharmacists
Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education (CPE). This activity is approved for a maximum of 22.75 contact hours under the ACPE universal activity numbers:
39th Annual CFS®: Innovative Cancer Therapy for Tomorrow®
New York Marriott Marquis
New York, NY 10036
Exciting new breakthroughs and rapid changes continue to occur in the management of solid and hematologic malignancies. Just this past year, practice-changing diagnostic, therapeutic, and supportive care strategies have entered clinical practice, and many more are poised to enter the field. The application of optimized testing approaches, locoregional and systemic therapies, including the use of chemotherapies, targeted therapies, immunotherapies, alone and in combination, along with multimodal strategies, continue to drive improved outcomes across multiple lines of care. Critical knowledge, competence, and performance gaps among practitioners must be addressed to ensure that these approaches are effectively and safely integrated into professional practice.
Each year, the Chemotherapy Foundation Symposium® (CFS®), brings together more than 2000 healthcare professionals for 3 days, with the aim of promoting the delivery of evidence-based, state-of-the-art cancer care for both routine and the most challenging clinical scenarios. At the 39th Annual CFS®, our internationally renowned faculty will provide you with expert insights on the latest developments in cancer therapeutics, offering an unparalleled opportunity to learn how innovative approaches fit into existing treatment paradigms to optimize care and outcomes for your patients with cancer.
Physicians' Education Resource®’s top priority is ensuring the safety and security of our attendees, staff, and operational personnel. We are dedicated to remaining informed about the ongoing COVID-19 pandemic at the global and local levels. As we develop the programming for this activity, Physicians' Education Resource® will follow the guidelines to optimize health and conditions for attendees during the event. Ongoing updates on Physicians' Education Resource®'s plans related to this event, including education and programming, will continue to be available at https://www.gotoper.com/conferences/chemo/meetings/39th-annual-chemotherapy-foundation-symposium-innovative-cancer-therapy-for-tomorrow. Please note attendance at any public event increases the risk of contracting COVID-19 or other airborne illness, and attendees assume all risk associated with attendance. Any attendees who feel ill, regardless of their symptoms, should not attend this event.
Benefits of Attending
- Incorporate the latest clinical data and evidence-based strategies into your practice
- Learn experts’ viewpoints on areas of clinical uncertainty
- Network with the top minds in oncology
- 100 Experts. 25 Tumor Types. 3 Days. 1 Meeting. Something for everyone!
This educational activity is directed toward oncologists, hematologists, nurses, nurse practitioners, and pharmacists involved in the treatment/management of patients with cancer. Radiotherapists, immunologists, fellows, physician assistants, researchers, case managers, and other healthcare professionals interested in the treatment of cancer are also invited to attend.
Upon successful completion of this educational activity, you should be better prepared to:
- Determine the most appropriate testing strategies to identify molecular marker and treatment targets while stratifying risk to inform clinical decision-making in cancer management
- Describe key practice-changing clinical trial results that inform appropriate diagnostic and treatment approaches for patients with hematologic malignancies and solid tumors
- Identify evidence-based immunotherapeutic, chemotherapeutic, and targeted treatment strategies to optimize clinical outcomes
- Delineate implementation strategies for multidisciplinary teams to anticipate and proactively manage treatment-related toxicities
- Review practice-changing evidence presented at major conferences, and apply these findings to optimize the care of patients with cancer
Professor of Medicine, Hematology and Medical Oncology
Director of Clinical Research, Multiple Myeloma Program
Associate Director of Clinical Research, Mount Sinai Cancer Clinical Trials Office
Icahn School of Medicine at Mount Sinai
New York, NY
Associate Professor, Johns Hopkins School of Medicine
Clinical Director of Medical Oncology
Johns Hopkins Sidney Kimmel Cancer Center
Sibley Memorial Hospital
Associate Attending Physician
Vice Chair, Oncology (Manhattan) Dept of Medicine
Clinical Director, Breast Medicine Service
Section Head, Triple Negative Breast Cancer Clinical Research Program
Memorial Sloan Kettering Cancer Center
Associate Professor of Medicine
Weill Cornell Medicine
New York, NY
Registration fees include breakfast, breaks, reception(s), and e-syllabus materials.
3 Ways to Register
- Online: Click here.
- Phone: Please call +1-(888)-949-0045 or +1-(609)-378-3701 (credit cards only).
- Fax: +1-(609)-257-0705 (credit cards only).
Physicians' Education Resource®, LLC - CFSC21
2 Clarke Drive
Cranbury, NJ 08512
|Live Advanced||Live On-site||Virtual Advanced||Virtual Week of|
|Nurses, PAs, Other Health Care Professionals||$249||$349||$149||$179|
*FELLOWS registration must be accompanied by a letter from your director/chair stating current fellowship for discount. Cannot be combined with other discounts/coupon codes.
**INDUSTRY is defined by PER® as any person employed by a for-profit organization, including biotech, financial, and pharmaceutical.
For registration assistance, please email firstname.lastname@example.org, or call +1-(888)-949-0045 or +1-(609)-378-3701.
A cancellation fee of 25% will be assessed on refunds requested prior to September 3, 2021 and a 50% fee on refunds requested on September 4, 2021, through October 3, 2021. No refunds will be made after October 3, 2021. There is no charge for substitution. Substitutions can only be applied to the same conference and only two substitutions will be honored.
In the event of a meeting cancellation, full refunds will be processed within 30 days of the cancellation date.
Physicians' Education Resource®, LLC (PER®) fully complies with the legal requirements of the Americans with Disabilities Act (ADA) and the rules and regulations thereof. If any participant in this educational activity is in need of accommodations, please notify us in order to receive service. Please call +1-(609)-378-3701.
PER® reserves the exclusive rights to all recordings or reproductions of the conference and supporting materials. Unauthorized recording, by any means, is expressly prohibited. This includes, but is not limited to, recording of presentations or reproductions of supporting audio/visual materials, exhibits, and other supporting Continuing Education materials.
By attending a PER® conference, meeting or related activity ("Events"), all participants, attendees, exhibitors, sponsors, and guests ("you") create an agreement between you and PER® regarding the use and distribution of your image, including but not limited to your name, voice, and likeness ("Image"). By attending the Events, you acknowledge and agree that photographs, video, and/or audio recordings may be taken of you and you grant permission to PER® (and its agents) to utilize, in perpetuity, your Image in any electronic or print distribution, or by other means hereinafter created, both now and in the future, for any lawful purpose as determined by PER®.
Meeting information is accurate at the time of posting.
PER® complies with the Physician Payments Sunshine Act as part of the Affordable Care Act. Accordingly, we may be required to collect information on transfers of value provided to any covered recipient under the Act.
You must be logged in to PER to register for this meeting
Or Register for PER now
In case of onsite emergency:
Assumption of Risk and Waiver of Liability Relating to Coronavirus/COVID-19
I understand that the hazards of the novel coronavirus ("COVID-19") and have reviewed the Centers for Disease Control and Prevention ("CDC") current guidelines in regards to COVID-19. I acknowledge that while Physicians' Education Resource, LLC ("PER") ("Company") has put in place preventative measures to reduce the spread of COVID-19, Company cannot guarantee that I or anyone else will not become infected with COVID-19. I attest that if within the fourteen (14) days prior to the event, I am experiencing any symptoms of COVID-19, or I have been in close contact with anyone that has been diagnosed with COVID-19, then I will not attend the Activities. I shall follow any safety, social distancing, masking, and hygiene protocols that have been implemented at the Activities.
I hereby willingly and voluntarily choose to attend this PER event and related activities ("Activity"). I acknowledge and fully assume the risk and hazards of exposure to COVID-19 and that such exposure or infection may result in personal injury, illness, permanent disability, and death to myself, my spouse, children, unborn child, or relatives. I acknowledge that Company may share my personal information for the purpose of contact tracing if the need arises, and I hereby consent to the release of my personal information for such purpose. I hereby release covenant not to sue, forever discharge, and hold harmless Company and its affiliates from all liability claims and demands of whatever kind of nature, either in law or in equity, which arise or may hereafter arise from participating in the Activities. I assume all risks of losses, damages, or injuries that may be sustained while participating in the Activity. I understand and agree that this release includes any Claims based on the actions, omissions, or negligence of the venue, employees, vendors, agents, and representatives, whether a COVID-19 infection occurs before, during, or after participation in the Activity.
* By checking this box, you have read and understand the above and agree to its terms.